Coincidentally, Suzuki et al. in patients with heart failure showed that the inclusion of TMAO in the risk model, combined with clinical scores, improved risk stratification for in-hospital mortality, while the combination of TMAO and NT-proBNP would provide additional prognostic predictive information (63). This evidence concerns the gene NPPB and heart failure.